Eli Lilly and Company
(E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino)piperidine-1-- carboxylate for inhibiting CDK7
Last updated:
Abstract:
The present invention provides novel CDK7 inhibitors and pharmaceutical compositions thereof: ##STR00001## or a pharmaceutically acceptable salt thereof.
Status:
Grant
Type:
Utility
Filling date:
9 Nov 2018
Issue date:
12 Nov 2019